Jody Aufrichtig
Chief Executive Officer

Jody is an award-winning entrepreneur, business builder, impact investor, and philanthropist. A Chartered Accountant by training, he has built significant and rapid shareholder value in 19 businesses in a broad range of sectors including cannabis, private equity, travel and tourism, sport and leisure, as well as other industries. Jody previously headed up Canopy Growth’s African operations.

Marc Balkin
Board Member

Experienced Non Executive Director with a demonstrated history of working in the management consulting industry. Skilled in Emerging Markets, Entrepreneurship, Venture Capital, Private Equity, and Start-ups. Strong business development professional graduated from University of the Witwatersrand. Partner Di-Game and Former Partner Hasso Plattner Ventures. Mark has served on the investment committees of Enablis, First National Bank Vumela FutureMaker and Alithea IDF. He is also a Newcourt Board Member

Warwick Corden-Lloyd
Chief Financial Officer

Warwick is a Chartered Accountant and Certified Project Manager with over 17 years of work experience in the United Kingdom, the USA, and South Africa. Warwick brings a wide scope of experience ranging from advising the boards of publicly traded companies to strategy design for start-ups. Warwick served as VP Operations and Finance for Canopy Growth Africa and prior to that was the Head of Financial Accounting for Capitec Bank. He is also a CA charter holder from The South African Institute of Chartered Accountants and a member of The Institute of Chartered Accountants in England and Wales.

Seth Feuerstein
Board Member

Dr. Feuerstein has expertise across multiple areas of medicine. He is Faculty at Yale School of Medicine in the Department of Psychiatry. He is a founding board member of the Center for Biomedical and Interventional Technology at Yale and Executive Director of the Center for Digital Health, Innovation and Excellence. He teaches at the medical school and is the faculty advisor for Innovation in Healthcare at the Yale School of Medicine.

He works across multiple sectors in healthcare including health insurance, healthcare startups, healthcare investing, clinical care delivery innovation and early stage emerging medical technologies. He has serial successes for novel reimbursement in healthcare and is a Former C suite executive at a national health insurer.

Graham Patrick
Board Member

Graham Patrick is a fiduciary and governance specialist with extensive experience in cross-border wealth management and corporate structures. A qualified attorney, conveyancer, and notary, he is a Partner and Head of Family Office Mauritius at Stonehage Fleming, where he also serves as Managing Director of Stonehage Fleming (Mauritius) Limited and its subsidiaries.

He has held senior fiduciary roles at Nedbank Private Wealth and Standard Bank Private Clients, and serves as a director on multiple entities across Mauritius, South Africa, the BVI and other jurisdictions, including multiple listed entities. Graham is a member of the Fiduciary Institute of South Africa and holds degrees in commerce and law, as well as a Postgraduate Diploma in Financial Management.

Albert Garcia-Romeu
Chair, Scientific Advisory Board

Albert Garcia-Romeu, Ph.D., is an Associate Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine and the Susan Hill Ward Professor in Psychedelics and Consciousness. His research focuses on the effects of psychedelics, particularly psilocybin, in treating addiction. He earned his doctorate in psychology from Sofia University in 2012, studying self-transcendence and mental health, and completed a postdoctoral fellowship in behavioral pharmacology at Johns Hopkins, where he has conducted clinical trials for over 12 years.

Dr. Garcia-Romeu has authored over 70 peer-reviewed publications and led psilocybin studies on smoking cessation, Alzheimer’s, Lyme disease, ALS, substance use disorders, and major depression. His work has been widely covered in major media outlets, including The New York Times, National Geographic, Science, and Nature. He is a founding member of the Johns Hopkins Center for Psychedelic and Consciousness Research, serves on the Board of the College on Problems of Drug Dependence, and is an Associate Editor for Psychedelic Medicine. His research explores psychedelics’ clinical applications, real-world drug use, diversity in science, and spirituality in well-being.

Dr. Clive Ward-Able
Medical Director

Dr Clive Ward-Able is a physician and a pharmacist who has worked in the pharmaceutical industry for over 30 years with 23 of those at the executive level. He has worked in large and small pharmaceutical and biotechnology companies in Canada, US, UK, Switzerland and South Africa in the departments of R&D, medical affairs, marketing and sales.

His experience relates mostly to the medical aspect of therapeutic drug commercialization and has been involved with the launch of over 16 products in multiple therapeutic areas. He is the President of his consultant company, Clintell Inc, and has been acting as consultant Medical Director for numerous start-up companies for the past 4 years. He is currently a member of the Board of Directors for Clinical Trials Ontario.

Seth Feuerstein
Board Member

Dr. Feuerstein has expertise across multiple areas of medicine. He is Faculty at Yale School of Medicine in the Department of Psychiatry. He is a founding board member of the Center for Biomedical and Interventional Technology at Yale and Executive Director of the Center for Digital Health, Innovation and Excellence. He teaches at the medical school and is the faculty advisor for Innovation in Healthcare at the Yale School of Medicine.

He works across multiple sectors in healthcare including health insurance, healthcare startups, healthcare investing, clinical care delivery innovation and early stage emerging medical technologies. He has serial successes for novel reimbursement in healthcare and is a Former C suite executive at a national health insurer.

Jody Aufrichtig
Chief Executive Officer

Jody is an award-winning entrepreneur, business builder, impact investor, and philanthropist. A Chartered Accountant by training, he has built significant and rapid shareholder value in 19 businesses in a broad range of sectors including cannabis, private equity, travel and tourism, sport and leisure, as well as other industries. Jody previously headed up Canopy Growth’s African operations.

Dr. Neil Maresky
Global Head Clinical Development

Dr. Neil Maresky is the Chief Executive Officer of Psyence Group. Prior to this he was the Vice President Scientific Affairs AstraZeneca, Canada Inc. In addition to 17 years of experience in research-based pharmaceuticals, where he held positions with Wyeth, Bayer, and Novartis, including serving as Director of Drug Safety and Pharmaco-epidemiology, he has worked as a family physician, with experience in cardiology and emergency room care. Dr. Maresky has published in journals that include Human Vaccines, The Canadian Journal of Clinical Pharmacology.

He co-founded and built a charitable foundation that assists underprivileged families with overwhelming medical costs.

Taryn Vos
General Counsel

Taryn is a commercial and corporate attorney and oversees all legal and commercial administrative agreements for the company. She was previously Head of Legal, for Canopy Growth Africa. After working as an associate at Cliffe Dekker Hofmeyr, in Cape Town, she joined Solar Capital, a renewable energy company, as in-house legal counsel. Taryn has also served as legal advisor to Phelan Energy Group, Ltd.

Warwick Corden-Lloyd
Chief Financial Officer

Warwick is a Chartered Accountant and Certified Project Manager with over 17 years of work experience in the United Kingdom, the USA, and South Africa. Warwick brings a wide scope of experience ranging from advising the boards of publicly traded companies to strategy design for start-ups. Warwick served as VP Operations and Finance for Canopy Growth Africa and prior to that was the Head of Financial Accounting for Capitec Bank. He is also a CA charter holder from The South African Institute of Chartered Accountants and a member of The Institute of Chartered Accountants in England and Wales.

Dr. Clive Ward-Able
Medical Director

Dr Clive Ward-Able is a physician and a pharmacist who has worked in the pharmaceutical industry for over 30 years with 23 of those at the executive level. He has worked in large and small pharmaceutical and biotechnology companies in Canada, US, UK, Switzerland and South Africa in the departments of R&D, medical affairs, marketing and sales.

His experience relates mostly to the medical aspect of therapeutic drug commercialization and has been involved with the launch of over 16 products in multiple therapeutic areas. He is the President of his consultant company, Clintell Inc, and has been acting as consultant Medical Director for numerous start-up companies for the past 4 years. He is currently a member of the Board of Directors for Clinical Trials Ontario.